{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:37:36Z","timestamp":1791488256530,"version":"4.3.4"},"reference-count":99,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Systemic Lupus Erythematosus (SLE) is an autoimmune disease in which autoantibody production and cytokine dysregulation leads to systemic organ and tissue damage that can result in mortality. Although various environmental, hormonal, and genetic factors can contribute to disease pathogenesis, the cause of this disease is not known. Traditional treatment for this disease is centered around limiting inflammation using a variety of immunosuppresants including glucocorticosteroids as well as other therapeutics including anti-malarial drugs. More recently, selective immunosuppresives and biologics including Belimumab, a BAFF monoclonal antibody, and Anifrolumab, a monoclonal antibody that selectively binds to type 1 interferon receptor (INFAR1) blocking the biological activity of type 1 IFN, have been used with various success. It should be noted that BAFF is of particular relevance as signaling through BAFFR is a well characterized mechansim for non-canonical NF-\u03baB signaling. While the canonical NF-\u03baB pathway has been well studied and reported, the role of the non-canonical NF-\u03baB pathway has been less investigated as to its role in autoimmunity. This pathway has been implicated in influencing pro-inflammatory immune responses while also regulating lymphocyte development. In this review, we aim to provide clarity on the relationship between the non-canonical NF-\u03baB pathway and the role it plays in pathogenesis of SLE. The objective of this review is to summarize recent findings of the relationship of this pathway in autoimmunity and, more specifically, in lupus pathogenesis.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1588486","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:53:00Z","timestamp":1751421180000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["The path less traveled: the non-canonical NF-\u03baB pathway in systemic lupus erythematosus"],"prefix":"10.3389","volume":"16","author":[{"given":"Hilary","family":"Montano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irving Coy","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3345\/cep.2023.00605","article-title":"Systemic autoinflammatory disorders: autoinflammatory and autoimmune disorders","volume":"66","author":"Kim","year":"2023","journal-title":"Clin Exp Pediatr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","article-title":"Systemic lupus erythematosus: A review","volume":"331","author":"Siegel","year":"2024","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0677-6","article-title":"Autoimmunity and organ damage in systemic lupus erythematosus","volume":"21","author":"Tsokos","year":"2020","journal-title":"Nat Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30330","article-title":"An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management","volume":"4","author":"Ameer","year":"2022","journal-title":"Cureus"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-020-00212-9","article-title":"Systemic lupus erythematosus (SLE) therapy: the old and the new","volume":"7","author":"Basta","year":"2020","journal-title":"Rheumatol Ther"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2010.01.007","article-title":"Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis","volume":"30","author":"Ramos","year":"2010","journal-title":"Semin Nephrol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00668-1","article-title":"Global epidemiology of systemic lupus erythematosus","volume":"17","author":"Barber","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000001003","article-title":"Emerging biologic therapies for systemic lupus erythematosus","volume":"36","author":"Kato","year":"2024","journal-title":"Curr Opin Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-023-05306-5","article-title":"Current treatment of systemic lupus erythematosus: a clinician\u2019s perspective","volume":"43","author":"Katarzyna","year":"2023","journal-title":"Rheumatol Int"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00772","article-title":"Innate immune cells\u2019 Contribution to systemic lupus erythematosus","volume":"10","author":"Herrada","year":"2019","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4414\/smw.2010.12597","article-title":"Hormones, immune response, and pregnancy in healthy women and SLE patients","volume":"140","author":"Zen","year":"2010","journal-title":"Swiss Med Weekly"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI70231","article-title":"Protein microarray analysis reveals BAFF-binding autoantibodies in systemic lupus erythematosus","volume":"123","author":"Price","year":"2013","journal-title":"J Clin Invest"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1313.004","article-title":"BAFF overexpression is associated with autoantibody production in autoimmune diseases","volume":"1050","author":"Pers","year":"2005","journal-title":"Ann New York Acad Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315608254","article-title":"Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus","volume":"25","author":"Salazar-Camarena","year":"2016","journal-title":"Lupus"},{"key":"B17","doi-asserted-by":"publisher","first-page":"101936","DOI":"10.1016\/j.berh.2024.101936","article-title":"B cell activation and autoantibody production in autoimmune diseases","volume":"38","author":"Sun","year":"2024","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"R157","DOI":"10.1186\/ar3474","article-title":"Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus","volume":"13","author":"Dolff","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"B19","doi-asserted-by":"publisher","first-page":"109031","DOI":"10.1016\/j.clim.2022.109031","article-title":"T cell dysregulation in SLE","volume":"239","author":"Tenbrock","year":"2022","journal-title":"Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00159","article-title":"The regulatory T cell in active systemic lupus erythematosus patients: A systemic review and meta-analysis","volume":"10","author":"Li","year":"2019","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2021.04.005","article-title":"T cells in systemic lupus erythematosus","volume":"47","author":"Paredes","year":"2021","journal-title":"Rheum Dis Clin North Am"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1007078","article-title":"Dysregulation and chronicity of pathogenic T cell responses in the pre-diseased stage of lupus","volume":"13","author":"Ohmes","year":"2022","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.00276","article-title":"Dysregulation of signaling pathways due to differentially expressed genes from the B-cell transcriptomes of systemic lupus erythematosus patients \u2013 A bioinformatics approach","volume":"8","author":"Udhaya Kumar","year":"2020","journal-title":"Front Bioengineering Biotechnol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduction Targeted Ther"},{"key":"B25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/cr.2010.177","article-title":"Non-canonical NF-\u03baB signaling pathway","volume":"21","author":"Sun","year":"2011","journal-title":"Cell Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.52","article-title":"The non-canonical NF-\u03baB pathway in immunity and inflammation","volume":"17","author":"Sun","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2013.01.004","article-title":"Regulation of nuclear factor-\u03baB in autoimmunity","volume":"34","author":"Sun","year":"2013","journal-title":"Trends Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2013.07.006","article-title":"Genetic interaction between genes involved in NF-\u03baB signaling pathway in systemic lupus erythematosus","volume":"56","author":"Cen","year":"2013","journal-title":"Mol Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/207578","article-title":"Association of TNFAIP3 polymorphism with susceptibility to systemic lupus erythematosus in a Japanese population","volume":"2010","author":"Kawasaki","year":"2010","journal-title":"J Biomedicine Biotechnol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/ng.202","article-title":"Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus","volume":"40","author":"Musone","year":"2008","journal-title":"Nat Genet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2005.00341.x","article-title":"Analysis of the functional NFKB1 promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus","volume":"65","author":"Orozco","year":"2005","journal-title":"Tissue Antigens"},{"key":"B32","doi-asserted-by":"publisher","first-page":"15998","DOI":"10.3390\/ijms232415998","article-title":"Unraveling the link between interferon-\u03b1 and systemic lupus erythematosus: from the molecular mechanisms to target therapies","volume":"23","author":"Infante","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaut.2018.11.004","article-title":"NF-kB signaling in myeloid cells mediates the pathogenesis of immune-mediated nephritis","volume":"98","author":"Chalmers","year":"2019","journal-title":"J Autoimmun"},{"key":"B34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1600-065X.2011.01059.x","article-title":"Non-canonical NF-\u03baB signaling activation and regulation: principles and perspectives","volume":"244","author":"Razani","year":"2011","journal-title":"Immunol Rev"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2010.06.002","article-title":"NF-\u03baB inducing kinase: A key regulator in the immune system and in cancer","volume":"21","author":"Thu","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"B36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.gene.2016.03.008","article-title":"Study of pathway cross-talk interactions with NF-\u03baB leading to its activation via ubiquitination or phosphorylation: A brief review","volume":"584","author":"Ghosh","year":"2016","journal-title":"Gene"},{"key":"B37","doi-asserted-by":"publisher","first-page":"8470","DOI":"10.3390\/ijms21228470","article-title":"Targeting NF-\u03baB-inducing kinase (NIK) in immunity, inflammation, and cancer","volume":"21","author":"Pflug","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.3123pe18","article-title":"Controlling the fate of NIK: A central stage in noncanonical NF-\u03baB signaling","volume":"3","author":"Sun","year":"2010","journal-title":"Sci Signaling"},{"key":"B39","doi-asserted-by":"publisher","first-page":"ra96","DOI":"10.1126\/scisignal.aad9413","article-title":"The NF-\u03baB subunit RelB controls p100 processing by competing with the kinases NIK and IKK1 for binding to p100","volume":"9","author":"Fusco","year":"2016","journal-title":"Sci Signal"},{"key":"B40","doi-asserted-by":"publisher","first-page":"a000034","DOI":"10.1101\/cshperspect.a000034","article-title":"The NF-\u03baB family of transcription factors and its regulation","volume":"1","author":"Oeckinghaus","year":"2009","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.11.7688","article-title":"RelB modulation of IkappaBalpha stability as a mechanism of transcription suppression of interleukin-1alpha (IL-1alpha), IL-1beta, and tumor necrosis factor alpha in fibroblasts","volume":"19","author":"Xia","year":"1999","journal-title":"Mol Cell Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.11.024","article-title":"A pathway switch directs BAFF signaling to distinct NF\u03baB transcription factors in maturing and proliferating B cells","volume":"9","author":"Almaden","year":"2014","journal-title":"Cell Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2009.04007.x","article-title":"BAFF: a local and systemic target in autoimmune diseases","volume":"158","author":"Moisini","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2010.09.010","article-title":"Targeting BAFF in autoimmunity","volume":"22","author":"Davidson","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2008.12.009","article-title":"B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus","volume":"131","author":"Parameswaran","year":"2009","journal-title":"Clin Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"100037","DOI":"10.1016\/j.xcrm.2020.100037","article-title":"Pharmacological activation of non-canonical NF-\u03baB signaling activates latent HIV-1 reservoirs in vivo","volume":"1","author":"Pache","year":"2020","journal-title":"Cell Rep Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2015.69","article-title":"NIK promotes tissue destruction independently of the alternative NF-\u03baB pathway through TNFR1\/RIP1-induced apoptosis","volume":"22","author":"Boutaffala","year":"2015","journal-title":"Cell Death Differentiation"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0707959105","article-title":"Control of canonical NF-\u03baB activation through the NIK\u2013IKK complex pathway","volume":"105","author":"Zarnegar","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaf1129","article-title":"Late-phase synthesis of I\u03baB\u03b1 insulates the TLR4-activated canonical NF-\u03baB pathway from noncanonical NF-\u03baB signaling in macrophages","volume":"9","author":"Chatterjee","year":"2016","journal-title":"Sci Signaling"},{"key":"B50","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/ni.2065","article-title":"Crosstalk in NF-\u03baB signaling pathways","volume":"12","author":"Oeckinghaus","year":"2011","journal-title":"Nat Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.09.143","article-title":"p100, a precursor of NF-\u03baB2, inhibits c-Rel and reduces the expression of IL-23 in dendritic cells","volume":"453","author":"Mise-Omata","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1408552111","article-title":"p100\/I\u03baB\u03b4 sequesters and inhibits NF-\u03baB through kappaBsome formation","volume":"111","author":"Tao","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011247","article-title":"DYRK1a mediates BAFF-induced noncanonical NF-\u03baB activation to promote autoimmunity and B-cell leukemogenesis","volume":"138","author":"Li","year":"2021","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22911","article-title":"Non-canonical NFKB signaling endows suppressive function through FOXP3-dependent regulatory T cell program","volume":"9","author":"Sato","year":"2023","journal-title":"Heliyon"},{"key":"B55","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.rdc.2021.04.006","article-title":"B cells in systemic lupus erythematosus: from disease mechanisms to targeted therapies","volume":"47","author":"Canny","year":"2021","journal-title":"Rheum Dis Clin North Am"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2009.10.011","article-title":"The role of B cells in lupus pathogenesis","volume":"42","author":"Nashi","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.952304","article-title":"B cells in systemic lupus erythematosus: Targets of new therapies and surveillance tools","volume":"9","author":"Parodis","year":"2022","journal-title":"Front Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.01.046","article-title":"B-cell biology and development","volume":"131","author":"Pieper","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1172\/JCI78083","article-title":"Checkpoints that control B cell development","volume":"125","author":"Melchers","year":"2015","journal-title":"J Clin Invest"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401514","article-title":"Conditional deletion of NF-\u03baB\u2013inducing kinase (NIK) in adult mice disrupts mature B cell survival and activation","volume":"195","author":"Brightbill","year":"2015","journal-title":"J Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12967-016-0846-4","article-title":"Fn14-Fc suppresses germinal center formation and pathogenic B cells in a lupus mouse model via inhibition of the TWEAK\/Fn14 Pathway","volume":"14","author":"Min","year":"2016","journal-title":"J Trans Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41467-017-02672-0","article-title":"NF-\u03baB inducing kinase is a therapeutic target for systemic lupus erythematosus","volume":"9","author":"Brightbill","year":"2018","journal-title":"Nat Commun"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.716469","article-title":"NF-\u03baB: at the borders of autoimmunity and inflammation","volume":"12","author":"Barnabei","year":"2021","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201546081","article-title":"NF-\u03baB-inducing kinase is essential for B-cell maintenance in mice","volume":"46","author":"Hahn","year":"2016","journal-title":"Eur J Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00509","article-title":"Non-canonical NF-\u03baB signaling initiated by BAFF influences B cell biology at multiple junctures","volume":"4","author":"Gardam","year":"2014","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abn5410","article-title":"TRIM55 promotes noncanonical NF-\u03baB signaling and B cell\u2013mediated immune responses by coordinating p100 ubiquitination and processing","volume":"16","author":"Lin","year":"2023","journal-title":"Sci Signaling"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2423","article-title":"The kinase TBK1 controls IgA class switching by negatively regulating noncanonical NF-\u03baB signaling","volume":"13","author":"Jin","year":"2012","journal-title":"Nat Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.01.007","article-title":"Human T cell development, localization, and function throughout life","volume":"48","author":"Kumar","year":"2018","journal-title":"Immunity"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1874","article-title":"Autonomous role of medullary thymic epithelial cells in central CD4+ T cell tolerance","volume":"11","author":"Hinterberger","year":"2010","journal-title":"Nat Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1146\/annurev-immunol-051116-052320","article-title":"Thymic epithelial cells","volume":"35","author":"Abramson","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14218\/JCTH.2020.00063","article-title":"Noncanonical NF-\u03baB signaling pathway in liver diseases","volume":"9","author":"Chen","year":"2020","journal-title":"J Clin Trans Hepatol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-01955-9","article-title":"Autoreactive T cells target neoself-antigens in lupus","volume":"56","author":"Vogan","year":"2024","journal-title":"Nat Genet"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.11.7514","article-title":"A novel mutation in the nfkb2 gene generates an NF-\u03baB2 \u201cSuper repressor","volume":"179","author":"Tucker","year":"2007","journal-title":"J Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.030767","article-title":"Noncanonical NF-\u03baB signaling and the essential kinase NIK modulate crucial features associated with eosinophilic esophagitis pathogenesis","volume":"10","author":"Eden","year":"2017","journal-title":"Dis Models Mech"},{"key":"B75","doi-asserted-by":"publisher","first-page":"030006052210801","DOI":"10.1177\/03000605221080104","article-title":"NF-kB pathway is involved in microscopic colitis pathogenesis","volume":"50","author":"Pisani","year":"2022","journal-title":"J Int Med Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1303237","article-title":"T cell\u2013intrinsic function of the noncanonical NF-\u03baB pathway in the regulation of GM-CSF expression and experimental autoimmune encephalomyelitis pathogenesis","volume":"193","author":"Yu","year":"2014","journal-title":"J Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13075-015-0527-3","article-title":"Non-canonical NF-\u03baB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde","volume":"17","author":"Noort","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.03.004","article-title":"Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus","volume":"11","author":"Chan","year":"2012","journal-title":"Autoimmun Rev"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1520627112","article-title":"Dendritic cells require NIK for CD40-dependent cross-priming of CD8+ T cells","volume":"112","author":"Katakam","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1801530","article-title":"RelB deficiency in dendritic cells protects from autoimmune inflammation due to spontaneous accumulation of tissue T regulatory cells","volume":"203","author":"Andreas","year":"2019","journal-title":"J Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1038\/s44318-024-00182-6","article-title":"Non-canonical NF-\u03baB signaling limits the tolerogenic \u03b2-catenin-Raldh2 axis in gut dendritic cells to exacerbate intestinal pathologies","volume":"43","author":"Deka","year":"2024","journal-title":"EMBO J"},{"key":"B82","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41467-019-08581-8","article-title":"Intestinal non-canonical NF\u03baB signaling shapes the local and systemic immune response","volume":"10","author":"Ramakrishnan","year":"2019","journal-title":"Nat Commun"},{"key":"B83","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40168-017-0300-8","article-title":"Control of lupus nephritis by changes of gut microbiota","volume":"5","author":"Mu","year":"2017","journal-title":"Microbiome"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001263","article-title":"Interplay of NF-\u03baB and PPAR-\u03b3 transcription factors in patients with juvenile systemic lupus erythematosus","volume":"12","author":"Durmus","year":"2025","journal-title":"Lupus Sci Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1039\/D0MD00361A","article-title":"Pharmacological inhibition of NF-\u03baB-inducing kinase (NIK) with small molecules for the treatment of human diseases","volume":"12","author":"Cheng","year":"2021","journal-title":"RSC Medicinal Chem"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.860327","article-title":"Differential contribution of NF-\u03baB signaling pathways to CD4+ Memory T cell induced activation of endothelial cells","volume":"13","author":"Jeucken","year":"2022","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00484","article-title":"Inhibitory kappa B kinase \u03b1 (IKK\u03b1) inhibitors that recapitulate their selectivity in cells against isoform-related biomarkers","volume":"60","author":"Anthony","year":"2017","journal-title":"J Medicinal Chem"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V128.22.3959.3959","article-title":"Targeting ikk\u03b1 in CLL: inhibition of non-canonical NF-\u03bab signaling decreases survival and proliferation of CD40L-stimulated primary CLL cells","volume":"128","author":"Willmore","year":"2016","journal-title":"Blood"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118855","article-title":"Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes","volume":"98","author":"Koshy","year":"1996","journal-title":"J Clin Invest"},{"key":"B90","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.3390\/molecules29153515","article-title":"Design and synthesis of novel aminoindazole-pyrrolo[2,3-b]pyridine inhibitors of IKK\u03b1 That selectively perturb cellular non-canonical NF-\u03baB signalling","volume":"29","author":"Riley","year":"2024","journal-title":"Molecules"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2024.0701","article-title":"Effect of bortezomib treatment in multiple myeloma on blood coagulation function, renal function, immune function, and the NF-\u03baB pathway-associated indicators","volume":"86","author":"Tao","year":"2025","journal-title":"Br J Hosp Med (Lond)"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1744666X.2025.2497845","article-title":"Targeting the ubiquitin-proteasome pathway in systemic lupus erythematosus","author":"Mok","year":"2025","journal-title":"Expert Rev Clin Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2013.05.027","article-title":"Bay11\u20137082 attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-\u03baB activation","volume":"17","author":"Zhao","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"R87","DOI":"10.1186\/ar3014","article-title":"Inhibitor of I\u03baB kinase activity, BAY 11-7082, interferes with interferon regulatory factor 7 nuclear translocation and type I interferon production by plasmacytoid dendritic cells","volume":"12","author":"Miyamoto","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3382\/ps.0650786","article-title":"Intraperitoneal injections of tryptophan inhibit food intake in the fowl","volume":"65","author":"Lacy","year":"1986","journal-title":"Poult Sci"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.881182","article-title":"Investigation of the anti-inflammatory activity of fusaproliferin analogues guided by transcriptome analysis","volume":"13","author":"Kuang","year":"2022","journal-title":"Front Pharmacol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13046-022-02352-y","article-title":"The role of TBK1 in cancer pathogenesis and anticancer immunity","volume":"41","author":"Runde","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B98","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12038-023-00381-z","article-title":"STING upregulation mediates ferroptosis and inflammatory response in lupus nephritis by upregulating TBK1 and activating NF-\u03baB signal pathway","volume":"49","author":"Chen","year":"2024","journal-title":"J Biosci"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.4155\/ppa.13.31","article-title":"Small-molecule inhibitors of I\u03baB kinase (IKK) and IKK-related kinases","volume":"2","author":"Llona-Minguez","year":"2013","journal-title":"Pharm Pat Anal"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1588486\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:53:01Z","timestamp":1751421181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1588486\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":99,"alternative-id":["10.3389\/fimmu.2025.1588486"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1588486","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"article-number":"1588486"}}